Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer

Neoplasma

Volumn 57, Issue 3, 2010, Pages 198-206

  Narita, D ^a   Anghel, A ^a   Cimpean, A M ^a   Izvernariu, D ^a   Cireap, N ^a   Ilina, R ^a   Ursoniu, S ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Androgen receptor gene; Breast cancer; Estrogen receptor genes; Polymorphic tandem repeats; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICROSATELLITE DNA; PROSTATE SPECIFIC ANTIGEN; AR PROTEIN, HUMAN; ESTROGEN RECEPTOR;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; TANDEM REPEAT; BREAST TUMOR; CHEMISTRY; GENETICS; GENOTYPE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TANDEM REPEAT SEQUENCES;

EID: 77954633244     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_03_198     Document Type: Article

References (52)

1. DIAMANDIS EP, YU H, SUTHERLAND DJ. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994; 32: 301-310. doi:10.1007/ BF00666007
2. Yu H, DIAMANDIS EP, LEVESQUE M, GIAI M, ROAGNA R et al. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 1996; 40: 171-178. doi:10.1007/BF01806212
3. Yu H, LEVESQUE MA, CLARK GM, DIAMANDIS EP. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clin Cancer Res 1998; 4: 1489-1497.
4. BLACK MH, DIAMANDIS EP. The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 2000; 59: 1-14. doi:10.1023/ A:1006380306781
5. SAUTER ER, KLEIN G, WAGNER-MANN C, DIAMANDIS EP. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect Prev 2004; 28: 27-31. doi:10.1016/j.cdp.2003.11.003
6. PEEHL DM, COHEN P, ROSENFELD RG. The insulin-like growth factor system in the prostate. World J Urol 1995; 13: 306-311.
7. FORTIER AH, NELSON BJ, GRELLA DK, HOLADAY JW. Antiangiogenic activity of prostate-specific antigen. J Natl Cancer Inst 1999; 91: 1635-1640. doi:10.1093/jnci/91.19.1635
8. LAI LC, ERBAS H, LENNARD TW, PEASTON RT. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 1996; 66: 743-746. doi:10.1002/(SICI)1097-0215(19960611)66:6<743::AID-IJC6>3.0.CO;2-#
9. MONNE M, CROCE CM, YU H, DIAMANDIS EP. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res 1994; 54: 6344-6347.
10. YANG Q, NAKAMURA M, NAKAMURA Y, YOSHIMURA G, SUZUMA T. Correlation of prostate-specific antigen promoter polymorphism with clinicopathological characteristics in breast cancer. Anticancer Res 2002; 22: 1825-1828.
11. AGOFF SN, SWANSON PE, LINDEN H, HAWES SE, LAWTON TJ. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical and prognostic associations. Am J Clin Pathol 2003; 120: 725-731. doi:10.1309/42F00D0DJD0J5EDT
12. BAYER-GARNER IB, SMOLLER B. Androgen receptors: a marker of increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. Mod Pathol 2000; 13: 119-122. doi:10.1038/modpathol.3880021
13. ORTMANN J, PRIFTI S, BOHLMANN MK, REHBERGERSCHNEIDER S, STROWITZKI T, RABE T. Testosterone and 5a-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 2002; 16: 113-120. doi:10.1080/713603030
14. SOMBOONPORN W, DAVIS SR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 2004; 25: 374-388. doi:10.1210/er.2003-0016
15. CHAMBERLAIN NL, DRIVER ED, MIESFELD RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994; 22: 3181-3186. doi:10.1093/ nar/22.15.3181
16. IRVINE RA, MA H, YU MC, ROSS RK, STALLCUP MR, COETZEE GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 2000; 9: 267-274. doi:10.1093/hmg/9.2.267
17. STANFORD JL, JUST JJ, GIBBS M, WICKLUND KG, NEAL CL et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194-1198.
18. DOWSING AT, YONG EL, CLARK M, McLACHLAN RI, DE KRETSER DM, TROUNSON AO. Linkage between male infertility and trinucleotide repeat expansion in the androgenreceptor gene. Lancet 1999; 354: 640-643.
19. LA SPADA AR, WILSON EM, LUBAHN DB, HARDING AE, FISCHBECK KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77-79. doi:10.1038/352077a0
20. SAWAYA ME, SHALITA AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 1998; 3: 9-15.
21. SOWERS M, WILLING M, BURNS T, DESCHENES S, HOLLIS B et al. Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 1999; 14: 1411-1419. doi:10.1359/jbmr.1999.14.8.1411
22. REBBECK TR, KANTOFF PW, KRITHIVAS K, NEUHAUSEN S, BLACKWOOD MA et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 1999; 64: 1371-1377. doi:10.1086/302366
23. YU H, BHARAJ B, VASSILIKOS EJ, GIAI M, DIAMANDIS EP. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 2000; 59: 153-161. doi:10.1023/A:1006356502820
24. DEL SENNO L, AGUIARI GL, PIVA R. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet 1992; 1: 354. doi:10.1093/hmg/1.5.354
25. KUNNAS TA, LAIPPALA P, PENTTILA A, LEHTIMAKI T, KARHUNEN PJ. Association of polymorphism of human α estrogen receptor gene with coronary artery disease in men: a necropsy study. Br Med J 2000; 321: 273-274. doi:10.1136/ bmj.321.7256.273
26. COMINGS DE, MUHLEMAN D, JOHNSON P, MACMURRAY JP. Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatry 1999; 4: 374-377. doi:10.1038/ sj.mp.4000503
27. BECHERINI L, GENNARI L, MASI L, MANSANI R, MASSART F et al. Evidence of linkage disequilibrium between polymorphisms in the human estrogen receptor α gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet 2000; 9: 2043-2050. doi:10.1093/hmg/9.13.2043
28. GEORGIOU I, SYRROU M, BOUBA I, DALKALITSIS N, PASCHOPOULOS M et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999; 72: 164-166. doi:10.1016/S0015-0282(99)00198-3
29. TSUKAMOTO K, INOUE S, HOSOI T, ORIMO H, EMI M. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus. J Hum Genet 1998; 43: 73-74. doi:10.1007/s100380050043
30. WESTBERG L, BAGHAEI F, ROSMOND R, HELLSTRAND M, LANDEN M et al. Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001; 86: 2562-2568. doi:10.1210/jc.86.6.2562
31. FORSTI A, ZHAO C, ISRAELSSON E, DAHLMAN-WRIGHT K, GUSTAFSSON JA, HEMMINKI K. Polymorphisms in the estrogen receptor β gene and the risk of breast cancer: no association. Breast Cancer Res Treat 2003; 79: 409-413. doi:10.1023/A:1024020609833
32. NOTT SL, HUANG Y, FLUHARTY BR, SOKOLOV AM, HUANG M et al. Do estrogen receptor β polymorphisms play a role in the pharmacogenetics of estrogen signaling? Curr Pharmacogenomics Person Med. 2008; 6: 239-259.
33. NARITA D, CIMPEAN AM, ANGHEL A, RAICA M. Prostate specific antigen value as a marker in breast cancer. Neoplasma 2006; 53: 161-167.
34. NARITA D, ANGHEL A, MOTOC M. Prostate-specific antigen may serve as a pathological predictor in breast cancer. Rom J Morphol Embryol 2008, 49: 173-180.
35. HALL RE, CLEMENTS JA, BIRREL SN, TILLEY WD. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast. Br J Cancer 1998; 78: 360-365.
36. ANGHEL A, RAICA M, MARIAN C, URSONIU S, MITRASCA O. Combined profile of tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer. J Cancer Res Clin Oncol 2006; 132: 727-733. doi:10.1007/s00432-006-0121-9
37. MOINFAR F, OKCU M, TSYBROVSKYY O, REGITNIG P, LAX SF, et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 2003; 98: 703-711. doi:10.1002/cncr.11532
38. BHARAJ B, SCORILAS A, DIAMANDIS EP, GIAI M, LEVESQUE MA et al. Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter. Breast Cancer Res Treat 2000; 61: 111-119. doi:10.1023/A:1006459613498
39. MAJUMDAR S, DIAMANDIS EP. The promoter and the enhancer region of the prostate-specific antigen of the KLK3 (prostate specific antigen) gene is frequently mutated in breast tumors and in breast carcinoma cell lines. Br J Cancer 1999; 79: 1594-1602. doi:10.1038/sj.bjc.6690254
40. CASSON PR, ELKIND-HIRSCH KE, BUSTER JE, HORNSBY PJ, CARSON SA, SNABES MC. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997; 90: 995-998.
41. GIGUERE Y, DEWAILLY E, BRISSON J, AYOTTE P, LAFLAMME N et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 2001; 61: 5869-5874.
42. ELHAJI YA, GOTTLIEB B, LUMBROSO R, BEITEL LK, FOULKES WD, et al. The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40. Breast Cancer Res Treat 2001; 70: 109-116. doi:10.1023/A:1012942910375
43. HAIMAN CA, BROWN M, HANKINSON SE, SPIEGELMAN D, COLDITZ GA et al. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses'Health Study. Cancer Res 2002; 62: 1045-1049.
44. SUTER NM, MALONE KE, DALING JR, DOODY DR, OSTRANDER EA. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 2003; 12: 127-135.
45. DUNNING AM, MCBRIDE S, GREGORY J, DUROCHER F, FOSTER N, et al. No association between androgen or vitamin receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 1999; 20: 2131-2135. doi:10.1093/carcin/20.11.2131
46. COX DG, BLANCHE H, PEARCE CL, CALLE EE, COLDITZ GA et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res 2006; 8: R54.
47. WEDREN S, MAGNUSSON C, HUMPHREYS K, MELHUS H, KINDMARK A et al. Associations between Androgen and Vitamin D receptor Microsatellites and Postmenopausal Breast Cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1775-1783. doi:10.1158/1055-9965.EPI-06-1096
48. IOBAGIU C, LAMBERT C, NORMAND M, GENIN C. Microsatellite profile in hormonal receptor genes associated with breast cancer. Breast Cancer Res Treat 2006; 95: 153-159. doi:10.1007/s10549-005-9060-4
49. SPURDLE AB, ANTONIOU AC, DUFFY DL, PANDEYA N, KELEMEN L et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005; 7: R176-183. doi:10.1186/bcr971
50. GOTTELAND, M, DESAUTY G, DELARUE JC, LIU L and MAY E. Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues. Mol Cell Endocrinol 1995; 112: 1-13. doi:10.1016/0303-7207(95)03576-S
51. FOX EM, DAVIS RJ, SHUPNIK MA. ERβ in breast canceronlooker, passive player, or active protector? Steroids 2008; 73: 1039-1051. doi:10.1016/j.steroids.2008.04.006
52. ARNOLD JT, LIU X, ALLEN JD, LE H, MCFANN KK, BLACKMAN MR. Androgen receptor or estrogen receptor-β blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Prostate. 2007; 67: 1152-1162. doi:10.1002/ pros.20585